Difficult patients can get special treatment.
[[{"type":"media","view_mode":"media_crop","fid":"26857","attributes":{"alt":"","class":"media-image","id":"media_crop_268501859707","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"2562","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"height: 334px; width: 440px;","title":" ","typeof":"foaf:Image"}}]]
Can MRI-Based Deep Learning Improve Risk Stratification in PI-RADS 3 Cases?
January 30th 2025In external validation testing, a deep learning model demonstrated an average AUC of 87.6 percent for detecting clinically significant prostate cancer (csPCA) on prostate MRI for patients with PI-RADS 3 assessments.